PL3897694T3 - Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry - Google Patents

Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry

Info

Publication number
PL3897694T3
PL3897694T3 PL19835661.0T PL19835661T PL3897694T3 PL 3897694 T3 PL3897694 T3 PL 3897694T3 PL 19835661 T PL19835661 T PL 19835661T PL 3897694 T3 PL3897694 T3 PL 3897694T3
Authority
PL
Poland
Prior art keywords
atopic dermatitis
use against
collagen hydrolyzate
against atopic
hydrolyzate
Prior art date
Application number
PL19835661.0T
Other languages
English (en)
Inventor
Stephan Hausmanns
Steffen Oesser
Franziska DOLLE
Hans-Ulrich Frech
Original Assignee
Gelita Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gelita Ag filed Critical Gelita Ag
Publication of PL3897694T3 publication Critical patent/PL3897694T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/18Peptides; Protein hydrolysates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/01Hydrolysed proteins; Derivatives thereof
    • A61K38/012Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/65Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/318Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Rheumatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
PL19835661.0T 2018-12-21 2019-12-20 Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry PL3897694T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102018133374.9A DE102018133374A1 (de) 2018-12-21 2018-12-21 Kollagenhydrolysat zur Verwendung gegen Hautkrankheiten und Darmkrankheiten
PCT/EP2019/086839 WO2020128070A2 (de) 2018-12-21 2019-12-20 Kollagenhydrolysat zur verwendung gegen hautkrankheiten und darmkrankheiten

Publications (1)

Publication Number Publication Date
PL3897694T3 true PL3897694T3 (pl) 2025-07-07

Family

ID=69159741

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19835661.0T PL3897694T3 (pl) 2018-12-21 2019-12-20 Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry

Country Status (14)

Country Link
US (1) US12138297B2 (pl)
EP (1) EP3897694B1 (pl)
JP (1) JP7717609B2 (pl)
KR (1) KR20210106443A (pl)
CN (1) CN113271961A (pl)
AU (1) AU2019410881B2 (pl)
BR (1) BR112021010046A2 (pl)
CA (1) CA3122046A1 (pl)
DE (1) DE102018133374A1 (pl)
EA (1) EA202191686A1 (pl)
ES (1) ES3033462T3 (pl)
MX (1) MX2021007486A (pl)
PL (1) PL3897694T3 (pl)
WO (1) WO2020128070A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102020126594A1 (de) * 2020-10-09 2022-04-14 Gelita Ag Kollagenhydrolysat als Wirkstoff zum Verzögern der Alterung
DE102021214899A1 (de) 2021-12-22 2023-06-22 Gelita Ag Typ I-Kollagenpeptid zur therapeutischen Verwendung
WO2023213909A1 (en) 2022-05-04 2023-11-09 Rousselot Bv Collagen hydrolysate composition for reducing joint pain after exercise
US20260027188A1 (en) * 2022-07-29 2026-01-29 Lonza Greenwood Llc Method and Composition for Treating Conditions Associated with a Leaky Gut Barrier
JP7631623B2 (ja) 2022-08-31 2025-02-18 ルースロ ビーヴイ 集中治療後症候群(pics)の予防及び/又は治療に使用するためのコラーゲン加水分解物
IT202200022392A1 (it) 2022-10-31 2024-05-01 Uriach Consumer Healthcare S L Collagene idrolizzato, processo per la sua preparazione e suoi usi

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO115690B1 (ro) * 1998-06-17 2000-05-30 Institutul Naţional De Cercetare - Dezvoltare Pentru Ştiinţe Biologice Unguent antiacneic şi antiseboreic
RO115691B1 (ro) * 1998-06-17 2000-05-30 Institutul Naţional De Cercetare - Dezvoltare Pentru Ştiinţe Biologice Unguent antipsoriazis
HK1040629B (en) * 1998-12-23 2005-01-28 Idea Ag Improved formulations for local non-diffusive administration in vivo
DE10058772A1 (de) * 2000-11-27 2002-06-06 Falk Pharma Gmbh Verfahren zur Herstellung leicht löslicher Arzneimittelformulierungen und entsprechende Formulierungen
JP2011111434A (ja) 2009-11-30 2011-06-09 Obihiro Univ Of Agriculture & Veterinary Medicine 皮膚機能改善剤及びそれを含む飲食品
CN102652021A (zh) 2009-12-10 2012-08-29 罗蒂株式会社 特应性皮炎预防剂
DE102010060564A1 (de) * 2010-11-15 2012-05-16 Gelita Ag Verwendung von Kollagenhydrolysat zur Verbesserung der Gesundheit der menschlichen Haut, Haare und/oder Nägel
ES2492672T3 (es) * 2010-12-02 2014-09-10 Medskin Solutions Dr. Suwelack Ag Colágeno para su uso en el tratamiento de enfermedades cutáneas
AU2012344135B2 (en) * 2011-11-29 2017-01-05 Gelita Ag Collagen hydrolysate and use thereof
DE102012101911A1 (de) * 2012-03-07 2013-09-12 Gelita Ag Verwendung von Kollagenhydrolysat
US20160082087A1 (en) 2013-04-26 2016-03-24 Nitta Gelatin Inc. Whitening promoting agent or atopic dermatitis ameliorating agent
CN104382943A (zh) * 2014-10-20 2015-03-04 广西壮族自治区花红药业股份有限公司 鱼鳞提取物在制备治疗和/或预防银屑病药物方面的新用途
WO2019224035A1 (en) * 2018-05-24 2019-11-28 Almirall, S.A. Topical pharmaceutical compositions comprising a corticosteroid
DE102019202606A1 (de) * 2018-11-06 2020-05-07 Gelita Ag Rekombinante Herstellung eines Kollagenpeptidpräparates und dessen Verwendung

Also Published As

Publication number Publication date
MX2021007486A (es) 2021-08-05
ES3033462T3 (en) 2025-08-04
EP3897694A2 (de) 2021-10-27
EA202191686A1 (ru) 2021-11-08
DE102018133374A1 (de) 2020-06-25
CN113271961A (zh) 2021-08-17
AU2019410881A1 (en) 2021-06-10
AU2019410881B2 (en) 2025-07-10
CA3122046A1 (en) 2020-06-25
EP3897694B1 (de) 2025-04-23
WO2020128070A2 (de) 2020-06-25
KR20210106443A (ko) 2021-08-30
JP2022515392A (ja) 2022-02-18
US20210308231A1 (en) 2021-10-07
WO2020128070A3 (de) 2020-08-13
BR112021010046A2 (pt) 2021-08-17
JP7717609B2 (ja) 2025-08-04
US12138297B2 (en) 2024-11-12

Similar Documents

Publication Publication Date Title
PL3897694T3 (pl) Hydrolizat kolagenu do stosowania przeciwko atopowemu zapaleniu skóry
IL261627B (en) A method and system for optimizing and predicting demand response
PL3592037T3 (pl) Sposób i urządzenie do przełączania
IL255002B (en) Annuloplasty technologies
EP3626699A4 (en) SSAO INHIBITOR
PL3523053T3 (pl) Urządzenie do powlekania i przynależny sposób eksploatacji
EP3590577A4 (en) OBJECT TRACKING DEVICE
EP3571840A4 (en) RATE CONTROL
EP3725246C0 (en) MENISCUS REPAIR DEVICES, SYSTEMS AND METHODS
DK3589151T3 (da) Rullebaseret lukkesystem
EP3565081A4 (en) ELECTRICAL SUPPLY SYSTEM
PL3305035T3 (pl) Sposób i system do sterowania włączaniem świateł
EP3570139A4 (en) CONTROL DEVICE
DE112018006483A5 (de) Elektrochemisches System
DK3532772T3 (da) Strømforsyningssystem.
EP3795412A4 (en) POWER SYSTEM
DK3649164T3 (da) Modificerede polymerpolyoler
EP3614216A4 (en) CONTROL UNIT
PL3018979T3 (pl) Sposób działania i rozbudowy sieci oświetleniowej
EP3418851C0 (en) CONTROL BODY
BR112017027497A2 (pt) Abastecimento de água para um animal
DK3592297T3 (da) Vævsteknologistilladser
IL250618A0 (en) Motor control system and method
EP3653868A4 (en) HYDROELECTRIC SYSTEM
EP3449805A4 (en) Resectoscope